A Systematic Review of Lenvatinib and Sorafenib for Treating Progressive, Locally Advanced or Metastatic, Differentiated Thyroid Cancer After Treatment With Radioactive Iodine

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-6369-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) in Turkey

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Estimating the Economic Impact of Sorafenib in Treatment of Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma (DTC) That Is Refractory to Radioactive Iodine (RAI) Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Dietary Iodine Restriction in Preparation for Radioactive Iodine Treatment or Scanning in Well-Differentiated Thyroid Cancer: A Systematic Review

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2010English

Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Effectiveness of Chemotherapy in Advanced Differentiated Thyroid Cancer: A Systematic Review

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Differentiated Thyroid Cancer in Pediatric Population (≤18 Years): Postoperative Treatment With Radioactive Iodine (I-131)

Acta Clinica Croatica
Medicine
2019English

Thyroid Storm and Complete Heart Block After Treatment With Radioactive Iodine

Case Reports in Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Interferon-Alfa in the Treatment of Patients With Inoperable Locally Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review

Canadian Urological Association Journal
Urology
2013English

Design of RESILIENCE: A Phase 3 Trial Comparing Capecitabine in Combination With Sorafenib or Placebo for Treatment of Locally Advanced or Metastatic HER2-negative Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy